Social Media as Pharmacovigilance: The Potential for Patient Reports to Inform Clinical Research on Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists for Substance Use Disorders

The surge in popularity of semaglutide (Ozempic, Wegovy, Rybelsus) and other glucagon-like-peptide 1 (GLP-1) receptor agonists has been accompanied by widespread reports of unintended reductions in alcohol use (and other addictive behaviors) during treatment. With clinical trials of GLP-1 receptor a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of studies on alcohol and drugs 2024-01, Vol.85 (1), p.5-10
Hauptverfasser:	Bremmer, Michael P, Hendershot, Christian S
Format:	Artikel
Sprache:	eng
Schlagworte:	Addictive behaviors Alcohol use Candidates Clinical research Clinical trials Craving Diabetes Mellitus, Type 2 - drug therapy Drug use Drugs GLP-1 receptor agonists Glucagon Glucagon-Like Peptide 1 - therapeutic use Humans Neurobehavioral functioning Peptides Pharmacovigilance Popularity Preoccupation Social Media Social networks Substance use disorder Substance-Related Disorders - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!